REPLIGEN CORP - COMMON STOCK (RGEN)

Historical Holders from Q1 2014 to Q1 2025

Symbol
RGEN on Nasdaq
CUSIP
759916109
Type / Class
Equity / COMMON STOCK
Shares outstanding
56.2M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
56.2M
Holdings value
$8.09B
% of all portfolios
0.006%
Grand Portfolio weight change
+0%
Number of holders
427
Number of buys
178
Number of sells
-218
Average Value change %
0%
Average buys %
+0.001%
Average sells %
-0.002%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of REPLIGEN CORP - COMMON STOCK (RGEN)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
PRICE T ROWE ASSOCIATES INC /MD/ 12.7% $908M 7.14M T. Rowe Price Associates, Inc. Dec 31, 2024
EDDLEMAN ROY T 4.84% $344M 2.71M Roy T. Eddleman Living Trust Dec 31, 2024

Institutional Holders of REPLIGEN CORP - COMMON STOCK (RGEN)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 1.87M $238M +$1.78M $127.24 52
2024 Q4 56.2M $8.09B +$127M $143.94 427
2024 Q3 55.3M $8.23B +$2.81M $148.82 441
2024 Q2 56.1M $7.07B -$93.2M $126.06 445
2024 Q1 56.1M $10.3B -$397M $183.92 488
2023 Q4 58.1M $10.4B +$251M $179.80 458
2023 Q3 56.8M $9.03B +$368M $159.01 430
2023 Q2 54.4M $7.7B +$8.98M $141.46 437
2023 Q1 53.8M $9.05B +$69.2M $168.36 438
2022 Q4 52M $8.81B +$356M $169.31 429
2022 Q3 49.8M $9.31B +$136M $187.11 413
2022 Q2 49.8M $8.09B +$274M $162.40 382
2022 Q1 48.2M $9.06B +$206M $188.09 424
2021 Q4 47M $12.4B -$248M $264.84 481
2021 Q3 47.2M $13.6B +$279M $288.99 467
2021 Q2 46.3M $9.25B +$157M $199.62 422
2021 Q1 45.7M $8.87B +$75.6M $194.41 451
2020 Q4 45.7M $8.76B +$266M $191.63 439
2020 Q3 44.6M $6.58B -$39.4M $147.54 381
2020 Q2 45.1M $5.58B -$196M $123.61 361
2020 Q1 45.7M $4.41B +$308M $96.54 296
2019 Q4 43.5M $4.03B -$117M $92.50 294
2019 Q3 44.6M $3.42B -$7.85M $76.69 292
2019 Q2 44.7M $3.84B +$538M $85.95 264
2019 Q1 39.7M $2.34B +$48.5M $59.08 239
2018 Q4 39M $2.06B -$111M $52.74 233
2018 Q3 40.9M $2.27B +$69.2M $55.46 193
2018 Q2 40.5M $1.91B +$122M $47.04 186
2018 Q1 37.7M $1.36B +$31.5M $36.18 178
2017 Q4 36.7M $1.33B +$40.4M $36.28 174
2017 Q3 36.4M $1.39B +$29.8M $38.32 186
2017 Q2 33.9M $1.41B +$144M $41.44 192
2017 Q1 32.5M $1.14B +$158M $35.20 177
2016 Q4 32.1M $990M +$12.1M $30.82 177
2016 Q3 31.9M $961M +$47.3M $30.19 176
2016 Q2 30.4M $832M +$19.9M $27.36 180
2016 Q1 29.5M $791M +$36.5M $26.82 178
2015 Q4 28.4M $804M -$42.8M $28.29 172
2015 Q3 30M $835M -$19.6M $27.85 186
2015 Q2 29.8M $1.23B +$44.4M $41.27 170
2015 Q1 29.4M $890M +$18.9M $30.36 167
2014 Q4 28.8M $570M +$24.9M $19.80 160
2014 Q3 28.1M $560M -$3.44M $19.91 161
2014 Q2 28.1M $640M +$57.1M $22.79 161
2014 Q1 26.2M $337M +$14.8M $12.86 132